Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Distributes Ayushman cards to several beneficiaries
The company has entered into a three-year Deferred Prosecution Agreement
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
Subscribe To Our Newsletter & Stay Updated